Evidence map›Paper›PMID 40643466›Full record

ArticleCells2025

Novel In Vitro Selection of

Veera Vijaya Basamshetty, Vijay Kumar Gangipangi, Uppulapu Shravan Kumar, Santhosh Shanthi Bhupathi, Sridhar Reddy Kaulagari, Prashant Giri, Swapnil Sinha, Utpal Mohan, Konstantinos Sdrimas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Veera Vijaya BasamshettyDepartment of Medical Oncology, West Virginia Cancer Institute, West Virginia University, Morgantown, WV 26505, USA.ORCID 0000-0002-9174-4050
Vijay Kumar GangipangiDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Uppulapu Shravan KumarDepartment of Internal Medicine Carver College of Medicine University of Iowa, Iowa City, IA 52242, USA.
Santhosh Shanthi BhupathiDepartment of Pharmaceutical Sciences, West Virginia University, Morgantown, WV 26505, USA.ORCID 0000-0003-4423-3546
Sridhar Reddy KaulagariDepartment of Pharmaceutical Sciences, West Virginia University, Morgantown, WV 26505, USA.
Prashant GiriDepartment of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Swapnil SinhaIIT Guwahati TIDF BioNest, Guwahati 70005, India.
Utpal MohanNational Institute of Pharmaceutical Education and Research, Kolkata 70005, India.
Konstantinos SdrimasDepartment of Medical Oncology, West Virginia Cancer Institute, West Virginia University, Morgantown, WV 26505, USA.ORCID 0000-0002-6315-343X

Funding

WVU Flow Cytometry and Single Cell Core Facility (FCSCCF)P20GM121322 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Karen H Martin · 2018 to 2026
$22.4M
Department of Biotechnology (DBT) BT/PR16160/NER/95/87/2015NIGMS NIH HHS P20 GM121322West Virginia University Cancer Institute NA
6 · The paper itself

Abstract

The B Cell Lymphoma-2 (

Indexed as

DNA, CatalyticNeoplasmsProto-Oncogene Proteins c-bcl-2RNA, MessengerAnimalsApoptosisCell SurvivalFemaleHep G2 CellsHumansMCF-7 CellsMiceBCL2 protein, humanDNA, CatalyticProto-Oncogene Proteins c-bcl-2RNA, MessengerapoptosisBCL-2cancerDNAzymessynthetic biology

Identifiers

PMID40643466
PMCPMC12248697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.